59 related articles for article (PubMed ID: 25266640)
1. From Counting Mitoses to Ki67 Assessment: Technical Pitfalls in the New WHO Classification of Endocrine and Neuroendocrine Tumors.
Cree IA
Endocr Pathol; 2022 Mar; 33(1):3-5. PubMed ID: 35028827
[No Abstract] [Full Text] [Related]
2. Clinical Features of Pancreatic Neuroendocrine Microadenoma: A Single-Center Experience and Literature Review.
Okawa Y; Tsuchikawa T; Hatanaka KC; Matsui A; Tanaka K; Nakanishi Y; Asano T; Noji T; Nakamura T; Mitsuhashi T; Okamura K; Hatanaka Y; Hirano S
Pancreas; 2022 Apr; 51(4):338-344. PubMed ID: 35699685
[TBL] [Abstract][Full Text] [Related]
3. Northstar enables automatic classification of known and novel cell types from tumor samples.
Zanini F; Berghuis BA; Jones RC; Nicolis di Robilant B; Nong RY; Norton JA; Clarke MF; Quake SR
Sci Rep; 2020 Sep; 10(1):15251. PubMed ID: 32943655
[TBL] [Abstract][Full Text] [Related]
4. Organization and Integration of the Endocrine System.
Chrousos GP
Sleep Med Clin; 2007 Jun; 2(2):125-145. PubMed ID: 18516219
[No Abstract] [Full Text] [Related]
5. Correlation between radiologic features on contrast-enhanced CT and pathological tumor grades in pancreatic neuroendocrine neoplasms.
Xu W; Yan H; Xu L; Li M; Gao W; Jiang K; Wu J; Miao Y
J Biomed Res; 2020 Aug; 35(3):179-188. PubMed ID: 33637654
[TBL] [Abstract][Full Text] [Related]
6. Liver Tumor Burden in Pancreatic Neuroendocrine Tumors: CT Features and Texture Analysis in the Prediction of Tumor Grade and
Beleù A; Rizzo G; De Robertis R; Drudi A; Aluffi G; Longo C; Sarno A; Cingarlini S; Capelli P; Landoni L; Scarpa A; Bassi C; D'Onofrio M
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32517291
[TBL] [Abstract][Full Text] [Related]
7. The ENETS/WHO grading system for neuroendocrine neoplasms of the gastroenteropancreatic system: a review of the current state, limitations and proposals for modifications.
Cavalcanti MS; Gönen M; Klimstra DS
Int J Endocr Oncol; 2016 Aug; 3(3):203-219. PubMed ID: 30338051
[TBL] [Abstract][Full Text] [Related]
8. Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67.
Genç CG; Falconi M; Partelli S; Muffatti F; van Eeden S; Doglioni C; Klümpen HJ; van Eijck CHJ; Nieveen van Dijkum EJM
Ann Surg Oncol; 2018 Aug; 25(8):2467-2474. PubMed ID: 29789972
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors.
Luo G; Liu C; Cheng H; Jin K; Guo M; Lu Y; Long J; Xu J; Ni Q; Chen J; Yu X
Oncol Lett; 2017 Apr; 13(4):2454-2458. PubMed ID: 28454419
[TBL] [Abstract][Full Text] [Related]
10. [Classification and clinicopathological characteristics of gastroenteropancreatic neuroendocrine neoplasms].
Li Z
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):10-23. PubMed ID: 27045236
[TBL] [Abstract][Full Text] [Related]
11. Comparison of WHO 2000 and WHO 2010 classifications of gastroenteropancreatic neuroendocrine tumors.
Karakuş E; Helvacı A; Ekinci O; Dursun A
Turk J Gastroenterol; 2014 Feb; 25(1):81-7. PubMed ID: 24918137
[TBL] [Abstract][Full Text] [Related]
12. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
Klöppel G
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
[TBL] [Abstract][Full Text] [Related]
13. [Grading of neuroendocrine tumors].
Saeger W; Schnabel PA; Komminoth P
Pathologe; 2016 Jul; 37(4):304-13. PubMed ID: 27379621
[TBL] [Abstract][Full Text] [Related]
14. WHO 2010 classification of pancreatic endocrine tumors. is the new always better than the old?
Ricci C; Casadei R; Taffurelli G; D'Ambra M; Monari F; Campana D; Tomassetti P; Santini D; Minni F
Pancreatology; 2014; 14(6):539-41. PubMed ID: 25266640
[TBL] [Abstract][Full Text] [Related]
15. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
[TBL] [Abstract][Full Text] [Related]
16. [Classification of pancreatic neuroendocrine tumours: Changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future].
Scoazec JY; Couvelard A;
Ann Pathol; 2017 Dec; 37(6):444-456. PubMed ID: 29169836
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
